Conway v. C.R. Bard, Inc.

76 F. Supp. 3d 826, 2015 U.S. Dist. LEXIS 17056, 2015 WL 627928
CourtDistrict Court, D. Minnesota
DecidedFebruary 12, 2015
DocketCase No. 14-CV-1466 (PJS/BRT)
StatusPublished

This text of 76 F. Supp. 3d 826 (Conway v. C.R. Bard, Inc.) is published on Counsel Stack Legal Research, covering District Court, D. Minnesota primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Conway v. C.R. Bard, Inc., 76 F. Supp. 3d 826, 2015 U.S. Dist. LEXIS 17056, 2015 WL 627928 (mnd 2015).

Opinion

ORDER

PATRICK J. SCHILTZ, District Judge.

Plaintiffs Anthony and Philip Conway founded and operated Rochester Medical Corporation (“RMC”), a publicly traded medical-device company. C.R. Bard, Inc., (“Bard”) offered to purchase RMC at a very attractive price. There was a hitch, though: Bard would go forward with the deal only if the Conways would sign five-year non-compete agreements. The Con-ways reluctantly agreed to sign the non-compete agreements, Bard purchased RMC at the agreed-upon price, and the Conways were paid tens of millions of dollars for their stock and other interests in RMC.

Soon afterwards, however, the Conways experienced sellers’ remorse, particularly over the fact that, although they had been required to sign non-compete agreements for the deal to go forward, the per-share price that they received for their stock was the same as the per-share price received by the other stockholders. The Conways filed suit, alleging that the non-compete agreements are unenforceable under Minnesota law because they were not supported by consideration.

This matter is before the Court on Bard’s motion to dismiss. Because it is clear on the face of the complaint that the Conways did, in fact, receive consideration for signing the non-compete agreements, Bard’s motion is granted, and the complaint is dismissed.

[828]*828I. BACKGROUND1

The Conways founded and essentially operated RMC, which develops and manufactures catheters and other medical devices for sufferers of incontinence. Compl. ¶ 10. The Conways hold “numerous patents related to urinary incontinence devices,” and, in large part because of the Conways’ success as inventors, RMC “grew to become a leading developer, innovator, and marketer of continence care products worldwide.” Id. Anthony Conway served as RMC’s President and Chief Executive Officer, and Philip Conway served as Vice President of Production Technologies. Id. ¶ ¶ 11-12. Between them, the Conways owned 14% of the publicly traded shares of RMC. Id. ¶ 13.

In 2013, Bard and RMC began negotiating a transaction that, while styled as a merger, was in substance a sale of RMC to Bard. Id. ¶ 16. After months of negotiation, the two companies informally agreed on a purchase price of $20 per share. Id. ¶ ¶ 17-18. The complaint alleges — and the parties agree — that this represented “a significant premium to [RMC] shareholders.” Id. ¶ 16. Specifically, the $20-per-share price represented “a 53 percent premium over $13.09, the closing price of the Common Stock on the NASDAQ on August 30, 2013, the last full trading day before the public announcement of the merger agreement.” Id. ¶ 18.

The complaint alleges that “Rochester Medical Corporation and Bard reached an agreement on the terms for the proposed [sale] in August of 2013.” Id. ¶ 17. But the Conways concede that neither Bard nor RMC was legally obligated to go forward with the deal until it was approved by both companies’ boards of directors. Mot. Hr’g Transcript, Aug. 20, 2014, at 13 (hereinafter “T. 13”). RMC’s board approved the transaction on August 13, 2013. Compl. ¶ 19. Bard’s board also approved the transaction on or about August 13, but its approval was conditioned on both Anthony and Philip Conway signing non-compete agreements. Id. ¶ 20.

Bard, RMC, and the Conways negotiated over the course of several days about Bard’s demand that the Conways sign non-compete agreements. Id. ¶ 21. Bard was unwilling to go forward with the deal unless the Conways signed non-compete agreements, but the Conways were unwilling to sign non-compete agreements because they wanted to continue to work in the continence field. Id. Eventually, however, the Conways relented because they recognized that the sale “was in the best interests of [RMC’s] shareholders,” and they felt a fiduciary obligation to “the investors who had backed and supported [RMC].” Id. ¶ 22. After further haggling about the length of the non-compete agreements, the Conways each signed a five-year non-compete agreement. In the words of the complaint: “Given the fiduciary duty of Plaintiffs to act in the best interest of [RMC], and believing their refusal to sign the Non-Compete Agreement would jeopardize the merger, Plaintiffs ex[829]*829ecuted the Non-Competition Agreement ... on September 3, 2013, the same day in which [RMC] and Bard finalized the merger agreement.” Id. ¶ 25.

The non-compete agreements recite that the Conways were “key employees” of RMC who were “intimately involved in the Business” and had “detailed knowledge of the intellectual property and other confidential and proprietary information of the Business.” Compl. Ex. B at l.2 The agreements add that the Conways “intend[ ] to transfer the goodwill associated with” their interests in RMC. Id. at 1. In the agreements, the Conways represent that they had entered into the non-compete agreements “of [their] own free will” and for “good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged.” Id. at 1-2, 6. The amount of that “good and valuable consideration” is not clear from the complaint or its attachments, but Bard represents that the Conways were paid “probably close to $40 million” in connection with the sale of RMC, T. 51, and the Conways do not dispute that they received tens of millions of dollars for their stock and other interests in RMC.

After the RMC sale closed — and after the Conways cashed Bard’s checks — the Conways filed this lawsuit, essentially seeking to change the terms of the deal. The Conways do not seek to unravel the sale, nor do they offer to return the money that they received from Bard. Instead, the Conways seek to invalidate the non-compete agreements that they signed — the very non-compete agreements that Bard insisted on before it would purchase RMC. Although the Conways represented in the non-compete agreements that they had -received “good and valuable consideration” for the agreements — and although the Conways acknowledged “the receipt and sufficiency of’ that consideration — the Conways now claim that the non-compete agreements “provide[d] no consideration to Plaintiffs.” Compl. ¶ 33. As a result, the Conways argue, those agreements are “invalid, unenforceable,' null and void.” Id.

II. ANALYSIS

A. Standard of Review

Bard has moved to dismiss the Conways’ complaint under Fed.R.Civ.P. 12(b)(6), arguing that the complaint’s central claim— that the non-compete agreements were not supported by consideration — is not “plausible on its face.” Bell Atl. Corp. v. Twombly, 550 U.S. 544, 570, 127 S.Ct. 1955, 167 L.Ed.2d 929 (2007). The factual allegations in a complaint need not be detailed, but they must be sufficient to “raise a right to relief above the speculative level....” Id. at 555, 127 S.Ct. 1955. In assessing the sufficiency of the complaint, a court may disregard legal conclusions that are couched as factual allegations. See Ashcroft v. Iqbal, 556 U.S. 662, 678-79, 129 S.Ct. 1937, 173 L.Ed.2d 868 (2009).

B. Consideration

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Bell Atlantic Corp. v. Twombly
550 U.S. 544 (Supreme Court, 2007)
Ashcroft v. Iqbal
556 U.S. 662 (Supreme Court, 2009)
Miller v. Redwood Toxicology Laboratory, Inc.
688 F.3d 928 (Eighth Circuit, 2012)
Aten v. Scottsdale Insurance
511 F.3d 818 (Eighth Circuit, 2008)
Bond v. Charlson
374 N.W.2d 423 (Supreme Court of Minnesota, 1985)
Sanborn Manufacturing Co. v. Currie
500 N.W.2d 161 (Court of Appeals of Minnesota, 1993)
Marriage of Kielley v. Kielley
674 N.W.2d 770 (Court of Appeals of Minnesota, 2004)
National Recruiters, Inc. v. Cashman
323 N.W.2d 736 (Supreme Court of Minnesota, 1982)
Bess v. Bothman
257 N.W.2d 791 (Supreme Court of Minnesota, 1977)
Pine River State Bank v. Mettille
333 N.W.2d 622 (Supreme Court of Minnesota, 1983)
Wise v. Midtown Motors, Inc.
42 N.W.2d 404 (Supreme Court of Minnesota, 1950)
Freeman v. Duluth Clinic, Ltd.
334 N.W.2d 626 (Supreme Court of Minnesota, 1983)
Davies & Davies Agency, Inc. v. Davies
298 N.W.2d 127 (Supreme Court of Minnesota, 1980)
Franklin v. Carpenter
244 N.W.2d 492 (Supreme Court of Minnesota, 1976)
Peoples Cleaning Dyeing Co. Inc. v. Share
210 N.W. 397 (Supreme Court of Minnesota, 1926)
Mattes v. ABC Plastics, Inc.
323 F.3d 695 (Eighth Circuit, 2003)

Cite This Page — Counsel Stack

Bluebook (online)
76 F. Supp. 3d 826, 2015 U.S. Dist. LEXIS 17056, 2015 WL 627928, Counsel Stack Legal Research, https://law.counselstack.com/opinion/conway-v-cr-bard-inc-mnd-2015.